4.7 Article

Endocan Promotes Pro-Tumorigenic Signaling in Lung Cancer Cells: Modulation of Cell Proliferation, Migration and lncRNAs H19 and HULC Expression

Related references

Note: Only part of the references are listed.
Review Biochemistry & Molecular Biology

Proteoglycan Endocan: A multifaceted therapeutic target in Cancer

Ke-Fan Pan et al.

Summary: This article summarizes the applications of endocan in cancer diagnoses and prognoses, and discusses the aberrant molecular characteristics of endocan in cancer cells may be due to mislocalization. Defining the specific cellular roles of endocan will provide a promising diagnostic factor and therapeutic target for cancer patients.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2022)

Review Biochemical Research Methods

Tumor immune microenvironment lncRNAs

Eun-Gyeong Park et al.

Summary: This review discusses the specific expression of long non-coding ribonucleic acids (lncRNAs) in tumor and immune cells, summarizes their regulatory functions at the cell type level, and highlights the application of single-cell RNA-sequencing (scRNA-seq) in studying the cell type-specific functions of lncRNAs in the tumor immune microenvironment (TIME).

BRIEFINGS IN BIOINFORMATICS (2022)

Article Obstetrics & Gynecology

Long non-coding RNA H19 correlates with unfavorable prognosis and promotes cell migration and invasion in ovarian cancer

Hainong Ma et al.

Summary: The present study revealed that H19 was significantly upregulated in primary OC tissues and human OC cell lines. Patients with lower levels of H19 had a longer median PFS compared to those with high levels, indicating that overexpression of H19 was associated with poor prognosis in OC patients. Knockdown of H19 expression inhibited the migration and invasion capability of OC cell lines, while restoration of H19 significantly increased cell migration and invasion.

GINEKOLOGIA POLSKA (2022)

Review Medicine, Research & Experimental

The role of long non-coding RNAs in angiogenesis and anti-angiogenic therapy resistance in cancer

Junxia Liu et al.

Summary: Long non-coding RNAs (lncRNAs) play a crucial role in tumor angiogenesis and resistance to anti-angiogenic therapy. Understanding their functions and potential clinical applications is important for improving tumor treatment.

MOLECULAR THERAPY-NUCLEIC ACIDS (2022)

Article Oncology

Modeling extracellular matrix through histo-molecular gradient in NSCLC for clinical decisions

Camila Machado Baldavira et al.

Summary: This study investigated the prognostic value of epithelial-to-mesenchymal transition (EMT), Wnt signaling, and extracellular matrix (ECM) protein expression in non-small-cell lung carcinoma (NSCLC) patients. The findings identified a set of proteins that may play a significant role in predicting the prognosis of NSCLC patients.

FRONTIERS IN ONCOLOGY (2022)

Article Oncology

Effect of Long Noncoding RNA HULC on Proliferation, Migration, and Invasion of Osteosarcoma Cells

Ran Zhao et al.

Summary: This study found that HULC was significantly upregulated in osteosarcoma and enhanced the progression of osteosarcoma through targeting PTEN.

JOURNAL OF ONCOLOGY (2022)

Article Cell Biology

LncRNA H19 Promotes Cell Proliferation, Migration, and Angiogenesis of Glioma by Regulating Wnt5a/beta-Catenin Pathway via Targeting miR-342

Qin Zhou et al.

Summary: This study reveals that lncRNA H19 promotes the growth, migration, and angiogenesis of glioma by regulating the miR-342/Wnt5a/β-catenin signaling pathway, providing new therapeutic targets for glioma treatment.

CELLULAR AND MOLECULAR NEUROBIOLOGY (2022)

Review Cell Biology

Gene regulation by long non-coding RNAs and its biological functions

Luisa Statello et al.

Summary: Recent studies have shed new light on the biogenesis and functions of long non-coding RNAs (lncRNAs), showcasing their diverse roles in gene regulation and signaling pathways, particularly in the contexts of neuronal disorders, immune responses, and cancer. The discovery of unique biogenesis pathways and subcellular localizations of lncRNAs has opened up potential therapeutic avenues for targeting lncRNAs in various biological and pathophysiological conditions.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2021)

Article Oncology

ESM1 promotes triple-negative breast cancer cell proliferation through activating AKT/NF-KB/Cyclin D1 pathway

Wentong Liu et al.

Summary: The study found that ESM1 is overexpressed in TNBC cell lines and patient tissues, correlated with poor prognosis. Overexpression of ESM1 increases proliferation, migration, and invasion of TNBC cells, while knockdown of ESM1 has the opposite effects. ESM1 promotes the proliferation of TNBC cells through the Akt-dependent NF-kappa B/Cyclin D1 pathway.

ANNALS OF TRANSLATIONAL MEDICINE (2021)

Article Biochemistry & Molecular Biology

Endocan and Circulating Progenitor Cells in Women with Systemic Sclerosis: Association with Inflammation and Pulmonary Hypertension

Alberto Lo Gullo et al.

Summary: Systemic sclerosis (SSc) is characterized by early vasculopathy and fibrosis in various tissues. CD34+ cells and endocan were found to be potential markers for disease status in SSc, with correlations to inflammatory markers and pulmonary arterial pressure. These findings suggest a potential role for CD34+ progenitor cells and endocan in monitoring SSc patients with pulmonary arterial hypertension.

BIOMEDICINES (2021)

Review Genetics & Heredity

Metastasis Prevention: Focus on Metastatic Circulating Tumor Cells

Maxim E. Menyailo et al.

Summary: Metastasis, the spread of tumor cells from the primary site to other parts of the body, is a major cause of cancer-related deaths. Circulating tumor cells (CTCs) with stem-like and hybrid epithelial-mesenchymal phenotypes can evade immune surveillance and exhibit increased therapy resistance, contributing to the negative prognosis associated with distant metastasis. Targeting the molecular and cellular characteristics of metastatic CTCs, including CTC clusters, may hold promise for preventing metastasis and improving therapeutic outcomes.

MOLECULAR DIAGNOSIS & THERAPY (2021)

Review Cell Biology

ERK: A Double-Edged Sword in Cancer. ERK-Dependent Apoptosis as a Potential Therapeutic Strategy for Cancer

Reiko Sugiura et al.

Summary: The RAF/MEK/ERK signaling pathway regulates various cellular processes and its activation is linked to cell proliferation and cancer. Further research on the mechanisms of ERK activation is essential for developing effective cancer treatments.

CELLS (2021)

Article Biochemistry & Molecular Biology

Characteristics of the PI3K/AKT and MAPK/ERK pathways involved in the maintenance of self-renewal in lung cancer stem-like cells

Jingyuan Li et al.

Summary: This study established a clinically relevant model for recognizing lung cancer stem cells and investigated the roles of PI3K/AKT and MAPK/ERK pathways in lung cancer through bioinformatic analysis. Experimentally, it was confirmed that the PI3K/AKT pathway promotes proliferation in lung adenocarcinoma cells, while the MAPK/ERK pathway regulates the proliferation of lung cancer stem cells. These findings highlight the distinct and synergistic roles of oncogenic signaling pathways and stem cell signaling pathways in regulating lung cancer stem cell self-renewal.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)

Editorial Material Oncology

Special issue: Translating extracellular matrix: From cancer progression to therapeutics

Nikos K. Karamanos

SEMINARS IN CANCER BIOLOGY (2020)

Review Biochemistry & Molecular Biology

Roles of Proteoglycans and Glycosaminoglycans in Cancer Development and Progression

Jinfen Wei et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Cell Biology

ESM-1 promotes adhesion between monocytes and endothelial cells under intermittent hypoxia

Haili Sun et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2019)

Review Biochemistry & Molecular Biology

VEGF in Signaling and Disease: Beyond Discovery and Development

Rajendra S. Apte et al.

Review Oncology

AKT and ERK dual inhibitors: The way forward?

Zhe Cao et al.

CANCER LETTERS (2019)

Review Oncology

ESM-1: A Novel Tumor Biomaker and its Research Advances

Chen Li et al.

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2019)

Article Cell Biology

LncRNA H19 promotes lung cancer proliferation and metastasis by inhibiting miR-200a function

Yi Zhao et al.

MOLECULAR AND CELLULAR BIOCHEMISTRY (2019)

Review Oncology

Akt in cancer: Mediator and more

Sundaramoorthy Revathidevi et al.

SEMINARS IN CANCER BIOLOGY (2019)

Review Cell Biology

Long Non-Coding RNA in the Pathogenesis of Cancers

Yujing Chi et al.

CELLS (2019)

Review Pharmacology & Pharmacy

Targeting AKT for cancer therapy

Maryam Shariati et al.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2019)

Article Medicine, Research & Experimental

Long non-coding RNA HULC affects the proliferation, apoptosis, migration, and invasion of mesenchymal stem cells

Xiujun Li et al.

EXPERIMENTAL BIOLOGY AND MEDICINE (2018)

Article Ophthalmology

Endocan Blockade Suppresses Experimental Ocular Neovascularization in Mice

Ting Su et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2018)

Editorial Material Biochemistry & Molecular Biology

Matrix pathobiology-central roles for proteoglycans and heparanase in health and disease

Nikos K. Karamanos

FEBS JOURNAL (2017)

Review Biochemistry & Molecular Biology

Perspectives of long non-coding RNAs in cancer

Arunagiri Kuha Deva Magendhra Rao et al.

MOLECULAR BIOLOGY REPORTS (2017)

Review Biochemistry & Molecular Biology

AKT/PKB Signaling: Navigating the Network

Brendan D. Manning et al.

Review Pharmacology & Pharmacy

AKT in cancer: new molecular insights and advances in drug development

Prabhjot S. Mundi et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)

Review Cell Biology

Mechanisms and regulation of endothelial VEGF receptor signalling

Michael Simons et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)

Article Respiratory System

ERK and AKT phosphorylation status in lung cancer and emphysema using nanocapillary isoelectric focusing

Philip A. J. Crosbie et al.

BMJ OPEN RESPIRATORY RESEARCH (2016)

Review Biochemistry & Molecular Biology

The emerging role of IncRNAs in cancer

Maite Huarte

NATURE MEDICINE (2015)

Article Biochemistry & Molecular Biology

Up-regulated long non-coding RNA H19 contributes to proliferation of gastric cancer cells

Feng Yang et al.

FEBS JOURNAL (2012)

Article Biochemical Research Methods

NIH Image to ImageJ: 25 years of image analysis

Caroline A. Schneider et al.

NATURE METHODS (2012)

Review Biochemistry & Molecular Biology

Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting

Achilleas D. Theocharis et al.

FEBS JOURNAL (2010)

Article Clinical Neurology

Endocan Expression and Localization in Human Glioblastomas

Claude-Alain Maurage et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)

Review Biochemistry & Molecular Biology

MAP kinase signalling pathways in cancer

A. S. Dhillon et al.

ONCOGENE (2007)

Article Peripheral Vascular Disease

Vascular endocan is preferentially expressed in tumor endothelium

Md. Ruhul Abid et al.

MICROVASCULAR RESEARCH (2006)

Article Oncology

Endocan expression and relationship with survival in human non-small cell lung cancer

Bogdan Dragos Grigoriu et al.

CLINICAL CANCER RESEARCH (2006)

Article Critical Care Medicine

Molecular signatures in biopsy specimens of lung cancer

AC Borczuk et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)